S. African regulator approves Merck’s anti-COVID pill

Organ-on-chip system enables precise monitoring of 3D tumour tissue outside the body
17 February 2022
Cellular waste disposal study provides new insights into Parkinson’s and Alzheimer’s
17 February 2022

S. African regulator approves Merck’s anti-COVID pill

South Africa’s health products regulator said on Friday it had approved the use of Merck’s COVID-19 pill for high-risk adults.

Comments are closed.